Harvest Group Wealth Management, LLC Morpho Sys Ag Transaction History

Harvest Group Wealth Management, LLC

  • $154 Million
  • Q1 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Jul 31, 2020
SELL
$24.08 - $33.35 $5,634 - $7,803
-234 Closed
0 $0
Q2 2019

Jul 31, 2019
BUY
$23.24 - $26.76 $627 - $722
27 Added 13.04%
234 $5,000
Q1 2019

May 06, 2019
BUY
$22.55 - $29.84 $4,667 - $6,176
207 New
207 $5,000

Others Institutions Holding MOR

# of Institutions
43
Shares Held
1.84M
Call Options Held
79.8K
Put Options Held
688K
View Full List

About MorphoSys AG

MOR Quotes by TradingView
  • Ticker MOR
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 136,614,000
  • Description
  • MorphoSys AG, a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. It offers Tafasitamab, an antibody for the treatment of B cell malignancies, including diffuse large B-cell lymphoma, f...
More about MOR
Track This Portfolio

Track Harvest Group Wealth Management, LLC Portfolio

Follow Harvest Group Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harvest Group Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Harvest Group Wealth Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email